OSE Immunotherapeutics SA (EPA:OSE)
France · Delayed Price · Currency is EUR 3.334
-0.010 (-0.30%)
Aug 21, 2026, 5:35 PM CET
OSE Immunotherapeutics Market Cap
OSE Immunotherapeutics has a market cap or net worth of €78.42 million as of August 21, 2026. Its market cap has decreased by -46.92% in one year.
Market Cap
78.42M
Enterprise Value
92.06M
Revenue
2.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.33
ChartMarket Cap Chart
Since March 30, 2015, OSE Immunotherapeutics's market cap has decreased from 104.30M to 78.42M, a decrease of -24.82%. That is a compound annual growth rate of -2.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 78.42M | -32.09% |
| Dec 31, 2025 | 115.47M | -26.37% |
| Dec 31, 2024 | 156.83M | 94.71% |
| Dec 29, 2023 | 80.55M | -34.73% |
| Dec 30, 2022 | 123.40M | -34.26% |
| Dec 31, 2021 | 187.71M | 45.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Transgene | 221.30M |
| Cellectis | 208.64M |
| Innate Pharma | 179.20M |
| Sensorion | 141.55M |
| Adocia | 81.59M |
| ABIONYX Pharma | 68.96M |
| MaaT Pharma | 60.11M |
| THX Pharma Société Anonyme | 58.43M |